Memantine Hcl
Brand name: Memantine Hcl
Rank #140 of 500 drugs by total cost
$117.5M
Total Cost
2,268,098
Total Claims
$117.5M
Total Cost
42,973
Prescribers
$52
Cost per Claim
329,165
Beneficiaries
3,377,638
30-Day Fills
$2,735
Avg Cost/Provider
53
Avg Claims/Provider
About Memantine Hcl
Memantine Hcl (sold as Memantine Hcl) was prescribed 2,268,098 times by 42,973 Medicare Part D providers in 2023, costing the program $117.5M. At $52 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 137 | Insulin Regular, Human (Afrezza) | $119.4M | 143,017 |
| 138 | Ezetimibe (Ezetimibe) | $118.1M | 2,859,001 |
| 139 | Ambrisentan (Ambrisentan) | $117.7M | 23,927 |
| 140 | Memantine Hcl (Memantine Hcl) | $117.5M | 2,268,098 |
| 141 | Estradiol (Estradiol) | $115.7M | 1,412,386 |
| 142 | Vortioxetine Hydrobromide (Trintellix) | $113.9M | 197,873 |
| 143 | Asfotase Alfa (Strensiq) | $113.8M | 1,142 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology